Am J Physiol Cell Physiol AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 281: C1413-C1421, 2001;
0363-6143/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, A. R.
Right arrow Articles by Bubien, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, A. R.
Right arrow Articles by Bubien, J. K.
Vol. 281, Issue 5, C1413-C1421, November 2001

TRANSLATIONAL PHYSIOLOGY
Hyperactive ENaC identifies hypertensive individuals amenable to amiloride therapy

Artensie R. Carter1, Zhen Hong Zhou2, David A. Calhoun1, and James K. Bubien2

1 Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, and 2 Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294

Pathophysiological features of both primary aldosteronism and pseudohyperaldosteronism are hyperactive amiloride-sensitive epithelial Na+ channels (ENaC) and refractory hypertension. Peripheral blood lymphocytes express ENaC, which functions and is regulated similarly to ENaC expressed by renal principal cells. Thus it was hypothesized that individuals with either of these hypertensive etiologies could be identified by assessment of the function and regulation of peripheral blood lymphocyte ENaC, by whole cell patch clamp. We also tested the hypothesis that specific inhibition of hyperactive ENaC with amiloride could ameliorate the hypertension. To test these hypotheses, we solicited blood samples from normotensive, controlled hypertensive, and refractory hypertensive individuals. Lymphocytes were examined electrophysiologically to determine whether ENaC was hyperactive. All positive findings were from refractory hypertensive individuals. Nine refractory hypertensive patients had amiloride added to their hypertensive therapy. Amiloride normalized the blood pressure of four subjects. These individuals all had hyperactive ENaC. Amiloride had no effect on individuals with normal ENaC. These findings suggest that whole-cell patch clamp of peripheral blood lymphocytes can be used to identify accurately and rapidly hypertensive individuals who will respond to amiloride therapy.

sodium channel; lymphocytes; aldosterone


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. Oparil, M. A. Zaman, and D. A. Calhoun
Pathogenesis of Hypertension
Ann Intern Med, November 4, 2003; 139(9): 761 - 776.
[Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. E. Hall
The Promise of Translational Physiology
J Neurophysiol, February 1, 2003; 89(2): 646 - 647.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Z.-H. Zhou and J. K. Bubien
ENaC plays a role in regulated antibody secretion by hybridomas
Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1480 - C1491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E193 - E194.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L235 - L236.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F207 - F208.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1259 - R1260.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H803 - H804.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. E. Hall
The promise of translational physiology
J Appl Physiol, February 1, 2002; 92(2): 425 - 426.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. E. Hall
The promise of translational physiology
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1411 - C1412.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online